VEGFR2 Antikörper (Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase)) (pTyr951) (Biotin)

Details for Product anti-KDR Antibody No. ABIN2385212
Target
Bindungsspezifität
pTyr951
40
33
31
20
17
16
15
13
12
12
10
9
8
8
7
7
7
7
6
5
5
5
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
344
215
132
25
6
4
4
4
4
2
2
2
2
2
2
2
2
2
1
1
1
1
1
Wirt
Kaninchen
323
63
17
2
1
1
1
1
Klonalität
Polyklonal
Konjugat
Dieser VEGFR2 Antikörper ist konjugiert mit Biotin
36
21
17
17
13
10
10
8
8
8
8
8
3
3
3
3
3
2
2
2
2
2
1
1
Applikation
Immunohistochemistry (IHC), ELISA
249
167
129
107
75
49
29
26
21
14
13
13
11
7
4
4
2
1
Optionen
Immunogen Synthetic phosphopeptide corresponding to amino acid residues surrounding Tyr951 of human KDR/FLK1 (KLH).
Isotyp IgG
Kreuzreaktivität Human
Kreuzreaktivität (Details) Calculated cross reactivity: Hu
Produktmerkmale VEGFR-2, phosphorylated (Tyr951) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) (Biotin)
Reinigung Purified by immunoaffinity chromatography.
Target
Andere Bezeichnung VEGFR-2 (KDR Antibody Abstract)
NCBI Accession NP_002244
UniProt P35968
Pathways RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Buffer Supplied as a liquid in PBS, pH 7.2.
Lagerung -20 °C
Informationen zur Lagerung -20°C